I don’t know that they have announced the date, but I believe they do have a meeting for FDA decision (and hopefully approval on 525 mg vs 700 mg? This may not be a meeting, but could likely be the criteria for a larger pharma discussion about combo license as it directly impacts BLA submission timeline.